PB2442: BLINATUMOMAB REDIRECTS DONOR LYMPHOCYTES AGAINST CD19+ ALL WITHOUT INCREASING THE RISK OF BYSTANDER ALLOREACTIVITY AFTER HAPLOIDENTICAL HEMATOPOIETIC CELL TRANSPLANTATION.

Autor: Mancusi, Antonella, Zorutti, Francesco, Ruggeri, Loredana, Bonato, Samanta, Tricarico, Sara, Zei, Tiziana, Iacucci Ostini, Roberta, Viglione, Valerio, Sembenico, Rebecca, Cardinali, Valeria, Fabrizio Martelli, Massimo, Mecucci, Cristina, Paola Martelli, Maria, Carotti, Alessandra, Velardi, Andrea, Pierini, Antonio
Zdroj: HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
Databáze: Complementary Index
Externí odkaz: